The estimated Net Worth of Joan E Herman is at least 5.04 百万$ dollars as of 15 July 2024. Ms. Herman owns over 4,677 units of Ionis Pharmaceuticals Inc stock worth over 1,786,558$ and over the last 8 years she sold IONS stock worth over 0$. In addition, she makes 3,253,890$ as Director at Ionis Pharmaceuticals Inc.
Sign up
Ms. Herman IONS stock SEC Form 4 insiders trading
Joan has made over 9 trades of the Ionis Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 4,677 units of IONS stock worth 198,913$ on 15 July 2024.
The largest trade she's ever made was exercising 7,111 units of Ionis Pharmaceuticals Inc stock on 15 July 2021 worth over 302,431$. On average, Joan trades about 700 units every 25 days since 2016. As of 15 July 2024 she still owns at least 42,007 units of Ionis Pharmaceuticals Inc stock.
You can see the complete history of Ms. Herman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joan Herman biography
Joan Elizabeth Herman is Director of the Company. Ms. Herman Since 2008, Ms. Herman has served as President and Chief Executive Officer of Herman & Associates, a management consulting firm that specializes in advising private equity firms investing in healthcare. She has experience leading healthcare and payor companies, serving in several executive positions at Anthem (formerly WellPoint), including as President and Chief Executive Officer of several different business units. Ms. Herman also served as a Senior Vice President of Phoenix Life Insurance Company. Since January 2013, Ms. Herman has served on the board of directors for Encompass Health (formerly HealthSouth). She previously served on the boards of both Convergys and AARP Services, Inc. The Board believes Ms. Herman is uniquely suited to serve on the Board because of her experience leading healthcare and payor companies.
What is the salary of Joan Herman?
As the Director of Ionis Pharmaceuticals Inc, the total compensation of Joan Herman at Ionis Pharmaceuticals Inc is 3,253,890$. There are 5 executives at Ionis Pharmaceuticals Inc getting paid more, with Stanley Crooke having the highest compensation of 9,598,830$.
How old is Joan Herman?
Joan Herman is 66, she's been the Director of Ionis Pharmaceuticals Inc since 2019. There are 8 older and 17 younger executives at Ionis Pharmaceuticals Inc. The oldest executive at Ionis Pharmaceuticals Inc is Breaux Castleman, 79, who is the Independent Director.
What's Joan Herman's mailing address?
Joan's mailing address filed with the SEC is 2855 GAZELLE COURT, , CARLSBAD, CA, 92010.
Insiders trading at Ionis Pharmaceuticals Inc
Over the last 9 years, insiders at Ionis Pharmaceuticals Inc have traded over 32,069,332$ worth of Ionis Pharmaceuticals Inc stock. The most active insiders traders include Stanley T Crooke、B Lynne Parshall、Michael R Hayden. On average, Ionis Pharmaceuticals Inc executives and independent directors trade stock every 8 days with the average trade being worth of 445,289$. The most recent stock trade was executed by Richard S Geary on 28 August 2024, trading 651 units of IONS stock currently worth 32,159$.
What does Ionis Pharmaceuticals Inc do?
ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.
What does Ionis Pharmaceuticals Inc's logo look like?
Complete history of Ms. Herman stock trades at Ionis Pharmaceuticals Inc、Encompass Health Corp
Ionis Pharmaceuticals Inc executives and stock owners
Ionis Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Stanley Crooke,
Executive Chairman of the Board of Directors -
Brett Monia,
Chief Executive Officer, Director -
Richard Geary,
Senior Vice President - Development -
Elizabeth Hougen,
Senior Vice President, Finance and Chief Financial Officer -
Patrick O'Neil,
Senior Vice President, Legal, General Counsel, Chief Compliance Officer and Corporate Secretary -
Joan Herman,
Director -
B. Lynne Parshall,
Director -
Dr. Brett P. Monia Ph.D.,
Founder, CEO & Director -
Dr. Stanley T. Crooke,
Scientific Advisor -
Joseph Klein,
Independent Director -
Joseph Wender,
Independent Director -
Spencer Berthelsen,
Independent Director -
Breaux Castleman,
Independent Director -
Frederick Muto,
Independent Director -
Michael Hayden,
Independent Director -
Joseph Loscalzo,
Independent Director -
Peter Reikes,
Independent Director -
B. Lynne Parshall Esq., J.D.,
Sr. Strategic Advisor & Director -
C. Frank Bennett,
Chief Scientific Officer -
Dr. Richard S. Geary,
Exec. VP & Chief Devel. Officer -
Elizabeth L. Hougen,
Exec. VP of Fin. & CFO -
Patrick R. O'Neil Esq.,
Chief Legal Officer, Gen. Counsel & Corp. Sec. -
Dr. Eric E. Swayze Ph.D.,
Exec. VP of Research -
D. Wade Walke,
Investor Relations -
Onaiza Cadoret-Manier,
Chief Corporate Development and Commercial Officer -
Eric Swayze,
Senior Vice President - Research -
Dr. C. Frank Bennett,
Exec. VP & Chief Scientific Officer -
Darren Gonzales,
Chief Accounting Officer & Sr. VP -
Joel Edwards,
VP of Corp. Operations -
Damien Mc Devitt,
Chief Business Officer -
Sarah Boyce,
Chief Business Officer -
Joseph Baroldi,
EVP, Chief Business Officer -
Kyle Jenne,
EVP, Chf GL Pdt Str Ofcr -
Allene M. Diaz,
Director -
Brian Birchler,
EVP, Corp and Development Ops -
Eugene Schneider,
EVP, Chf Clinical Develop Ofcr -
Michael J. Yang,
Director